PLAU and colonic neoplasm: found that low concentrations of DCA can activate the β-catenin pathway and stimulate the expression of urokinase plasminogen activator (uPA), urokinase plasminogen activator receptor (uPAR), and cyclin D1, further promoting the proliferation of colon cancer cells (55).